David C Burdick

Title: The Innovative Contributions of David C Burdick

Introduction

David C Burdick is a notable inventor based in Guilderland, NY (US), recognized for his significant contributions to the field of chemistry and pharmaceuticals. With a total of four patents to his name, Burdick has made strides in the production of important compounds, particularly those related to cannabinoids.

Latest Patents

Among his latest patents, Burdick has developed a process for the production of delta-9-tetrahydrocannabinol. This invention involves treating a first intermediate compound with an organoaluminum-based Lewis acid catalyst, under conditions effective to produce the delta-9-tetrahydrocannabinol compound or its derivatives. Additionally, he has created a process for the preparation of cannabidiol or cannabidiolate compounds. This process entails reacting a first starting compound with a second starting compound in the presence of a metal triflate catalyst, which effectively forms the desired cannabidiol or cannabidiolate compound.

Career Highlights

Throughout his career, David C Burdick has worked with prominent companies such as Albany Molecular Research, Inc. and Cardax Pharmaceuticals, Inc. His work in these organizations has contributed to advancements in pharmaceutical research and development.

Collaborations

Burdick has collaborated with several professionals in his field, including Steven James Collier and Betina Biolatto. These collaborations have likely enhanced his innovative capabilities and broadened the impact of his inventions.

Conclusion

David C Burdick's contributions to the field of cannabinoid production and his collaborations with industry professionals highlight his role as a significant inventor. His work continues to influence advancements in pharmaceutical chemistry.